Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes
Clinical trial NCT02089126 · UNKNOWN
Trial details
- NCT number
- NCT02089126
- Sponsor
- LG Life Sciences
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-09-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.